Superparamagnetic iron oxide polyacrylic acid coated γ-Fe2O3 nanoparticles do not affect kidney function but cause acute effect on the cardiovascular function in healthy mice

Toxicology and Applied Pharmacology

Volumn 266, Issue 2, 2013, Pages 276-288

  Iversen, Nina K ^a   Frische, Sebastian ^a   Thomsen, Karen ^a   Laustsen, Christoffer ^b   Pedersen, Michael ^b   Hansen, Pernille B L ^c   Bie, Peter ^c   Fresnais, Jérome ^d   Berret, Jean Francois ^e   Baatrup, Erik ^a   Wang, Tobias ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d SORBONNE UNIVERSITÉ   (France)

^e UNIVERSITÉ PARIS DIDEROT   (France)

Author keywords

Acid base status; Cardiovascular function; Excretion; Glomerular filtration; Mouse; Nanoparticle distribution

Indexed keywords

POLYACRYLIC ACID; SUPERPARAMAGNETIC GAMMA IRON OXIDE NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL PH; ARTICLE; BLOOD PRESSURE; CARDIOTOXICITY; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; CYTOPLASM; DRUG ACCUMULATION; DRUG COATING; DRUG DISTRIBUTION; ENDOTHELIUM CELL; FEMALE; GLOMERULUS FILTRATION RATE; INDWELLING CATHETER; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; KUPFFER CELL; MALE; MEAN ARTERIAL PRESSURE; MESANGIUM CELL; MESENTERIC ARTERY; MOUSE; MYOGRAPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PODOCYTE; TRANSMISSION ELECTRON MICROSCOPY;

ACRYLIC RESINS; ANIMALS; BLOOD PRESSURE; FEMALE; FERRIC COMPOUNDS; GLOMERULAR FILTRATION RATE; HYDROGEN-ION CONCENTRATION; INJECTIONS, INTRAVENOUS; KIDNEY; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; MESENTERIC ARTERIES; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, TRANSMISSION; MUSCLE CONTRACTION; MYOGRAPHY; TIME FACTORS; TISSUE DISTRIBUTION;

MUS;

EID: 84871839579     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2012.10.014     Document Type: Article

References (63)

1. Albini A., Mussi V., Parodi A., Vetura A., Principi E., Tegami S., Rocchia M., Francheschi E., Sogno I., Cammarota R., Finzi G., Sessa F., Noonan D.M., Valbusa U. Interactions of single-wall carbon nanotubes with endothelial cells. Nanomedicine 2010, 6:277-288.
2. Allkemper T., Bremer C., Matuszewski L., Ebert W., Reimer P. Contrast-enhanced blood-pool MR angiography with optimized iron oxides: effect of size and dose on vascular contrast enhancement in rabbits. Radiology 2002, 223:432-438.
3. Apte K., Hede S. Cardiovascular effects of cetyl trimethyl ammonium bromide-protected gold nanoparticles. Indian J. Pharmacol. 2007, 39:210-213.
4. Ballou B., Ernst L.A., Andreko S., Harper T., Fitzpatrick J.A.J., Waggoner A.S., Bruchez M.P. Sentinel lymph node imaging using quantum dots in mouse tumor models. Bioconjug. Chem. 2007, 18(2):389-396.
5. Behrendt D., Ganz P. Endothelial function. From vascular biology to clinical applications. Am. J. Cardiol. 2002, 21:40-48.
6. Berret J.-F., Sandre O., Mauger A. Size distribution of superparamagnetic particles determined by magnetic sedimentation. Langmuir 2007, 23(6):2993-2999.
7. Briley-Saebo K., Bjorneud A., Grant D., Ahlstrom H., Berg T., Kindberg G.M. Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging. Cell Tissue Res. 2004, 316:315-323.
8. Bruce R.J., Djamali A., Shinki K., Michel S.J., Fine J.P., Pozniak M.A. Background fluctuation of kidney function versus contrast-induced nephrotoxicity. AJR Am. J. Roentgenol. 2009, 192:711-718.
9. Butz G.M., Davisson R.L. Long-term telemetric measurements of cardiovascular parameters in awake mice: a physiological genomics tool. Physiol. Genomics 2001, 5:89-97.
10. Byrd L., Sherman R.L. Radiocontrast-induced acute renal failure: a clinical and pathophysiologic review. Medicine 1979, 58:270-279.
11. Cameron J.N. A rapid method for determination of total carbon dioxide in small blood samples. J. Appl. Physiol. 1971, 31:632-634.
12. Chambrey R., Goosens D., Bourgeois S., Picard N., Bloch-Faure M., Leviel F., Geoffroy V., Cambillau M., Colin Y., Pailard M., Houillier P., Cartron J.P., Eladari D. Genetic ablation of Rhbg in the mouse does not impair renal ammonium excretion. Am. J. Physiol. Renal Physiol. 2005, 289:F1281-F1290.
13. Chanteau B., Fresnais J., Berret J.-F. Electrosteric enhanced stability of functional sub-10 nm cerium and iron oxide particles in cell culture medium. Langmuir 2009, 25(16):9064-9070.
14. Chen J., Tan M., Nemmar A., Song Wong M., Zhang G., Li Y. Quantification of extrapulmonary translocation of intratracheal-instilled particles in vivo in rats: effect of lipopolysaccharide. Toxicology 2006, 222:195-201.
15. Choi H.S., Liu W., Misra P. Renal clearance of quantum dots. Nat. Biotechnol. 2007, 25:1165-1170.
16. Chouly C., Pouliquen D., Lucet I., Jeune J.J., Jallet P. Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution. J. Microencapsul. 1996, 13:245-255.
17. Cochran S.T., Wong W.S., Roe D.J. Predicting angiography-induced acute renal function impairment: clinical risk model. AJR Am. J. Roentgenol. 1983, 141:1027-1033.
18. Dockery D.W., Pope C.A., Xu X., Spengler J.D., Ware J.H., Fay M.E., Ferris B.G., Speizer F.E. An association between air pollution and mortality in six U.S. cities. N. Engl. J. Med. 1993, 329:1753-1759.
19. Farokhzad O.C., Langer R. Nanomedicine: developing smarter therapeutic and diagnostic modalities. Adv. Drug Deliv. Rev. 2006, 58:1456-1459.
20. Gordon T., Nadziejko C., Schlesinger R., Chen L.C. Pulmonary and cardiovascular effects of acute exposure to concentrated ambient particulate matter in rats. Toxicol. Lett. 1998, 96-97:285-288.
21. Gu F.X. Targeted nanoparticles for cancer therapy. Nano Today 2007, 2:14-21.
22. Gupta A.K., Naregalkar R.R., Vaidya V.D., Gupta M. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomedicine 2007, 2(1):23-39.
23. Hafner P., Grimaldi R., Capuano P., Capasso G., Wagner C.A. Pendrin in the mouse kidney is primarily regulated by Cl-excretion but also by systemic metabolic acidosis. Am. J. Physiol. Cell Physiol. 2008, 295:1658-1667.
24. Hamoir J., Nemmar A., Halloy D., Wirth D., Vincke G., Vanderplasschen A., Nemery B., Gustin P. Effect of polystyrene particles on lung microvascular permeability in isolated perfused rabbit lungs: role of size and surface properties. Toxicol. Appl. Pharmacol. 2003, 190:278-285.
25. Hussain S.M., Hess K.L., Gearhart J.M., Geiss K.T., Schlager J.J. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol. In Vitro 2005, 19:975-983.
26. Iversen N.K., Malte H., Baatrup E., Wang T. The normal acid-base status in mice. Respir. Physiol. Neurobiol. 2012, 180:252-257.
27. Jain K.K. Nanomedicine: application of nanobiotechnology in medical practice. Med. Princ. Pract. 2008, 17:89-101.
28. Legramante J.M., Valentini F., Magrini A., Palleschi G., Sacco S., Iavicoli I., Pallante M., Moscone D., Galante A., Bergamaschi E., Bergamaschi A., Pietroiusti A. Cardiac autonomic regulation after lung exposure to carbon nanotubes. Hum. Exp. Toxicol. 2009, 28:369.
29. Liong M., Lu J., Kovochich M., Xia T., Ruehm S.G., Nel A.E., Tamanoi F., Zink J.I. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2008, 5:889-896.
30. Longmire M., Choyke P.L., Kobayashi H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine 2008, 3(5):703-717.
31. 4-nanoparticle induces hepatic and renal tissue injury via oxidative stress in mice. Nanomedicine 2012, 7:4809-4818.
32. Magari S.R., Hauser R., Schwartz J., Williams P.L., Smith T.J., Christiani D.C. Association of heart rate variability with occupational and environmental exposure to particulate air pollution. Circulation 2001, 104:986-991.
33. Mattson D.L. Long-term measurement of arterial blood pressure in conscious mice. Am. J. Physiol. 1998, 274:564-570.
34. McCord J.M. Effects of positive iron status at a cellular level. Nutr. Rev. 1996, 54:85-88.
35. Mo Y., Wan R., Chien S., Tollerud D.J., Zhang Q. Activation of endothelial cells after exposure to ambient ultrafine particles: the role of NADPH oxidase. Toxicol. Appl. Pharmacol. 2009, 236:183-193.
36. Mulvany M.J., Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res. 1977, 41:19-26.
37. Mulvany M.J., Hansen P.K., Aalkjaer C. Direct evidence that greater contractility of resistance vessels in spontaneous hypertensive rats is associated with a narrowed lumen, a thicker media and an increased number of smooth muscle cell layers. Circ. Res. 1978, 43:854-864.
38. Nash K., Hafeez A., Hou S. Hospital-acquired renal insufficiency. Am. J. Kidney Dis. 2002, 39:930-936.
39. Nemmar A., Vanbilloen H., Hoylaerts M.F., Hoet P.H.M., Verbruggen A., Nemery B. Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster. Am. J. Respir. Crit. Care Med. 2001, 164:1665-1668.
40. Neuberger T., Schopf B., Hofmann H., Hofmann M., von Rechenberg B. Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system. J. Magn. Magn. Mater. 2005, 293:483-496.
41. Oberdörster G., Sharp Z., Atudorei V., Elder A., Gelein R., Lunts A., Kreyling W., Cox C. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J. Toxicol. Environ. Health 2002, 1087(65):1531-1543.
42. Pekkanen J., Peters A., Hoek G., Tiittanen P., Brunekreef B., de Hartog J., Heinrich J., Ibald-Mulli A., Kreyling W.G., Lanki T., Timonen K.L., Vanninen E. Particulate air pollution and risk of ST-segment depression during repeated submaximal exercise tests among subjects with coronary heart disease: the Exposure and Risk Assessment for Fine and Ultrafine Particles in Ambient Air (ULTRA) study. Circulation 2002, 106:933-938.
43. Persson P.B., Tepel M. Contrast medium-induced nephropathy: the pathophysiology. Kidney Int. 2006, 100:8-10.
44. Peters K., Unger R.E., Kirkpatrick C.J., Gatti A.M., Monari E. Effects of nano-scaled particles on endothelial cell function in vitro: studies on viability, proliferation and inflammation. J. Mater. Sci.-Mater. Med. 2004, 15:321-325.
45. Pope C.A., Burnett R.T., Thun M.J., Calle E.E., Krewski D., Ito K., Thurston G.D. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 2002, 287:1132-1141.
46. Pope C.A., Burnett R.T., Thurston G.D., Thun M.J., Calle E.E., Krewski D., Godleski J.J. Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation 2004, 109:71-77.
47. Rety F., Clement O., Siauve N., Cuenod C.A., Carnot F., Sich M., Buisine A., Frija G. MR lymphography using iron oxide nanoparticles in rats: pharmacokinetics in the lymphatic system after intravenous injection. J. Magn. Reson. Imaging 2000, 12:734-739.
48. Rosen J.E., Chan L., Shieh D.-B., Gu F.X. Iron oxide nanoparticles for targeted cancer imaging and diagnostics. Nanomedicine 2012, 8:275-290.
49. Safi M., Sarrouj H., Sandre O., Mignet N., Berret J.-F. Interactions between sub-10-nm iron and cerium oxide nanoparticles and 3T3 fibroblasts: the role of the coating and aggregation state. Nanotechnology 2010, 21(14):10.
50. Safi M., Courtois J., Seigneuret M., Conjeaud H., Berret J.-F. The effects of aggregation and protein corona on the cellular internalization of iron oxide nanoparticles. Biomaterials 2011, 32(35):9353-9363.
51. Samet J.M., Dominici F.R., Curriero F.C.D., Coursac I., Zeger S.L. Fine particulate air pollution and mortality in 20 U.S. cities, 1987-1994. N. Engl. J. Med. 2000, 343:1742-1749.
52. Siggaard-Andersen O. Blood Gases. Fundamentals of Clinical Chemistry 1976, 854-944. W.B. Saunders Company, Philadelphia. N.W. Tietz (Ed.).
53. Stern S.T., McNeil S.E. Nanotechnology safety concerns revisited. Toxicol. Sci. 2008, 2008(101):4-21.
54. Swoap S.J., Weinshenker D., Palmiter R.D., Garber G. Dbh(-/-) mice are hypotensive, have altered circadian rhythms, and have abnormal responses to dieting and stress. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 286:108-113.
55. Thakor A.S., Luond R., Paulmurugan R., Lin F.I., Kempen P., Zavaleta C., Chu P., Massoud T.F., Sinclair R., Gambhir S.S. The fate and toxicity of Raman-active silica-gold nanoparticles in mice. Sci. Transl. Med. 2011, 3:79ra33.
56. Toprak O. Conflicting and new risk factors for contrast induced nephropathy. J. Urol. 2007, 178:2277-2283.
57. Vallet M., Picard N., Loffing-Cueni D., Fysekidis M., Bloch-Faure M., Deschênes, Breton S., Meneton P., Loffing J., Aronson P.S., Chambrey R., Eladari D. Pendrin regulation in mouse kidney primarily is chloride-dependent. J. Am. Soc. Nephrol. 2006, 17:2153-2163.
58. Van Vliet B.N., McGuire J., Chafe L., Loenard A., Joshi A., Montani J.-P. Phenotyping the level of blood pressure by telemetry in mice. Clin. Exp. Pharmacol. Physiol. 2006, 33:1007-1015.
59. Wall S.M., Kim Y.H., Stanley L., Glapion D.M., Everett L.A., Green E.D., Verlander J.W. NaCl restriction upregulates renal Slc26a4 through subcellular redistribution. Hypertension 2004, 44:982-987.
60. Weir M.P., Gibson J.F., Peters T.J. Haemosiderin and tissue damage. Cell Biochem. Funct. 1984, 2:186-194.
61. Wisner E.R., Amparo E.G., Vera D.R., Brock J.M., Barlow T.W., Griffey S.M., Drake C., Katzberg R.W. Arabinogalactan-coated superparamagnetic iron oxide: effect of particle size in liver MRI. J. Comput. Assist. Tomogr. 1995, 19:211-215.
62. Wisse E., Doucet D., Van Bossuyt H. A transmission electron microscopic study on the uptake of AMI-25 by sinusoidal liver cells. Cells of the Hepatic Sinusoid 1991, vol. 3:534-539. Kupffer Cell Foundation, The Netherlands. E. Wisse (Ed.).
63. Zhu M.-T., Feng W.-Y., Wang Y., Wang B., Wang M., Ouyang H., Zhao Y.-L., Chai Z.-F. Particokinetics and extrapulmonary translocation of intratracheally installed ferric oxide nanoparticles in rats and the potential health risk assessment. Toxicol. Sci. 2008, 107(2):342-351.